In a filing, BioCardia Inc revealed its President and CEO Altman Peter acquired Company’s shares for reported $1170.0 on Dec 17 ’25. In the deal valued at $1.30 per share,900 shares were bought. As a result of this transaction, Altman Peter now holds 267,966 shares worth roughly $0.33 million.
Then, Altman Peter bought 200 shares, generating $274 in total proceeds. Upon buying the shares at $1.37, the President and CEO now owns 267,066 shares.
Before that, STERTZER SIMON H bought 398,400 shares. BioCardia Inc shares valued at $498,000 were divested by the Director at a price of $1.25 per share. As a result of the transaction, STERTZER SIMON H now holds 591,054 shares, worth roughly $0.73 million.
Dawson James downgraded its BioCardia Inc [BCDA] rating to a Neutral from a a Buy in a research note published recently.
Price Performance Review of BCDA
On Monday, BioCardia Inc [NASDAQ:BCDA] saw its stock fall -3.15% to $1.23. Over the last five days, the stock has lost -3.15%. BioCardia Inc shares have fallen nearly -38.50% since the year began. Nevertheless, the stocks have fallen -43.58% over the past one year. While a 52-week high of $3.20 was reached on 04/29/25, a 52-week low of $1.00 was recorded on 09/18/25.
Levels Of Support And Resistance For BCDA Stock
The 24-hour chart illustrates a support level at 1.1467, which if violated will result in even more drops to 1.0635. On the upside, there is a resistance level at 1.3266. A further resistance level may holdings at 1.4233.
How much short interest is there in BioCardia Inc?
A steep rise in short interest was recorded in BioCardia Inc stocks on 2025-12-15, dropping by 8164.0 shares to a total of 0.17 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.18 million shares. There was a decline of -4.88%, which implies that there is a negative sentiment for the stock.
